therapeutic HIV vaccine (antigen-specific immune cell activation, African strains) (Haikou VTI)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nametherapeutic HIV vaccine (antigen-specific immune cell activation, African strains) (Haikou VTI)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUganda

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesHaikou Vti Biological Institute

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHaikou Vti Biological Institute

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A